IP Library › Granted Patent US 12,253,516
Granted Patent B2
US 12,253,516 · App. 18/431,875 · Granted Mar 18, 2025

Optical coherence tomography in an intelligent automated in vitro fertilization and intracytoplasmic sperm injection platform

Inventors: Alejandro Chavez-Badiola (Mexico City, MX); Gerardo Mendizabal-Ruiz (Guadalajara, MX); Adolfo Flores-Saiffe Farias (Zapopan, MX); Cesar Millan (Zapopan, MX); Vladimir C. Ocegueda Hernandez (Zapopan, MX); Victor Manuel Rico Botero (Guadalajara, MX); Alan Murray (Greenwich, CT)
Assignee: Conceivable Life Sciences Inc.
G01N33/5091A61B17/425C12N5/0604
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,253,516
App. No.
18/431,875
Granted
Mar 18, 2025
Kind
B2
Abstract

A method for automated, artificial-intelligence-based egg identification using optical coherence tomography (OCT) includes positioning an OCT imaging system head in proximity to a biological sample containing an oocyte, wherein the OCT is operatively coupled to an artificial intelligence/machine learning system (AI/ML system) and an imaging system, wherein the imaging system includes a camera system, and a lighting system. The method includes creating at least one three-dimensional image of the oocyte using the OCT, AI/ML system, and imaging system. The method includes using the AI/ML system to analyze the three-dimensional image, wherein an analysis includes detection of a polar body's presence or absence based at least in part on planar views of the oocyte.

Claims (27)

1. A method for automated, artificial-intelligence-based egg identification using optical coherence tomography (OCT), the method comprising:

positioning an OCT imaging system head in proximity to a biological sample containing an oocyte, wherein:

the OCT imaging system head is operatively coupled to an artificial intelligence/machine learning system (AI/ML system) and an imaging system, and

the imaging system includes a camera system and a lighting system;

creating a first three-dimensional image of the oocyte using the OCT imaging system head, the AI/ML system, and the imaging system;

using the AI/ML system to analyze the first three-dimensional image, wherein analyzing the first three-dimensional image includes detection of a presence or an absence of a polar body based on planar views of the oocyte; and

in response to identifying the presence of the polar body:

denuding the oocyte from the biological sample;

after denuding the oocyte, creating a second three-dimensional image of the oocyte using the OCT imaging system head, the AI/ML system, and the imaging system; and

using the AI/ML system to analyze the second three-dimensional image, wherein analyzing the second three-dimensional image includes automatically locating a presence or an absence of a meiotic spindle.

2. The method of claim 1 wherein the oocyte is a plurality of oocytes.

3. The method of claim 1 wherein the OCT imaging system head is a polarized sensitive OCT imaging system head.

4. The method of claim 1 wherein the OCT imaging system head is placed above the biological sample.

5. The method of claim 1 wherein the OCT imaging system head is placed beneath the biological sample.

6. The method of claim 1 wherein the OCT imaging system head is placed to a side of the biological sample.

7. The method of claim 1 wherein the OCT imaging system head is movable to a plurality of locations relative to the biological sample from which locations images may be produced.

8. The method of claim 1 wherein the lighting system includes polarized lighting.

9. The method of claim 1 wherein the first three-dimensional image is an amalgamation of a plurality of images that are combined into the first three-dimensional image.

10. The method of claim 9 wherein the amalgamation of the plurality of images includes image components from the OCT imaging system head and at least one other microscopy system.

11. The method of claim 1 wherein the first three-dimensional image includes virtual elements that are simulated.

12. The method of claim 1 wherein the AI/ML system and the imaging system automatically assess the meiotic spindle to form a predictive algorithm to determine a probability of an egg adequately maturing.

13. The method of claim 1 wherein the AI/ML system and the imaging system automatically assess the meiotic spindle to form a predictive algorithm to determine a probability of whether an egg will mature with further incubation.

14. The method of claim 1 wherein the AI/ML system and the imaging system automatically define a best positioning of the oocyte for use during an injection.

15. The method of claim 1 , wherein the AI/ML system and the imaging system automatically assess membrane integrity.

16. The method of claim 1 wherein the second three-dimensional image includes virtual elements that are simulated.

17. The method of claim 1 further comprising making a maturity assessment of the oocyte based on the detection of the presence or the absence of the meiotic spindle.

18. The method of claim 1 further comprising using polarized lighting directed towards the biological sample containing the oocyte.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2024
From: CHAVEZ-BADIOLA, ALEJANDRO; MURRAY, ALAN; COHEN, JACQUES; ABRAM, JOSHUA; MENDIZABAL-RUIZ, GERARDO; FLORES-SAIFFE FARIAS, ADOLFO; MILLAN, CESAR; VALENCIA-MURILLO, ROBERTO; OCEGUEDA HERNANDEZ, VLADIMIR C.; SILVESTRI, GIUSEPPE; COSTA-BORGES, NUNO; HERNANDEZ, ESTEFANIA; ALVAREZ, ANGEL; GREGORIO ESPINOZA FIGUEROA, JOSÉ; MANUEL RICO BOTERO, VICTOR; MANUEL MEDINA PEREZ, VICTOR; AGUAYO, JOHANN; GARBARINI, WILLIAM NICHOLAS, JR.; MARTÍNEZ, DAVID; PIZANO PARRA, ALEJANDRA; MURILLO, ANAIS LEROY; MAURICIO LÓPEZ GÓMEZ, CARLOS; ZAMARRIPA GONZALEZ, VALENTIN; ACOSTA GOMEZ, FATIMA J.; REYES LLAMAS, MARIO; KUKU, STEPHANIE
To: CONCEIVABLE LIFE SCIENCES INC.
Reel/Frame 068470/0904 →
Continuity (3)
Continuation PCTUS2024013428 · Jan 30, 2024
Provisional Application 63523258 · Jun 26, 2023
Related Publication 20240426812A1 · Dec 26, 2024
References Cited (20)
US 11494578B1 · Chian · 2022 [cited by applicant]
US 20130337487A1 · Loewke · 2013 [cited by examiner]
US 20140297199A1 · Osten · 2014 [cited by examiner]
US 20150252328A1 · Woodruff · 2015 [cited by examiner]
US 20170140535A1 · Hamamah · 2017 [cited by examiner]
US 20200305967A1 · Getman · 2020 [cited by applicant]
US 20220189640A1 · Wessels Wells · 2022 [cited by examiner]
US 20220358655A1 · Wessels Wells · 2022 [cited by examiner]
US 20230093989A1 · Mahajan · 2023 [cited by examiner]
US 20230303959A1 · Blanchard · 2023 [cited by applicant]
CN 112401994A · 2021 [cited by applicant]
WO WO0004929A1 · 2000 [cited by examiner]
WO WO2016001754A2 · 2016 [cited by examiner]
Zhu et al. “Study of Robotic System for Automated Oocyte Manipulation” (2017), IEEE, 2017 Intern'l Conf on Manipulation, Automation, and Robotics at Small Scales (MARSS). [cited by applicant]
Abdullah et al., “Automation in ART: Paving the Way for the Future of Infertility Treatment,” Published online Aug. 2022, Reproductive Sciences, vol. 30: 1006-1016. [cited by applicant]
Casciani et al., “Are we approaching automated assisted reproductive technology? Sperm analysis oocyte manipulation, and insemination,” Fertil Steril, vol. 2, No. 3: 189-203, 2021. [cited by applicant]
Trottmann, et al., “Ex vivo investigations on the potential of optical coherence tomography (OCT) as a diagnostic tool for reproductive medicine in a bovine model,” vol. 9, No. 1-2: 129-137, 2016. [cited by applicant]
Fan, et al., “Optimized Optical Coherence Tomography Imaging with Hough Transform-Based Fixed-Pattern Noise Reduction,” IEEE Access, vol. 6, 32087-32096, 2018. [cited by applicant]
Zhai, et al., “Automated Denudation of Oocytes,” Micromachines, 2022. [cited by applicant]
Targosz, et al., “Semantic segmentation of human oocyte images using deep neural networks,” BioMedical Engineering, 20:40, 2021. [cited by applicant]